Comparison between Direct Sequencing and INNO-liPA Methods for HPV Detection and Genotyping in Thai Women

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 4, 2011, Pages 989-994

  Chinchai, Teeraporn ^a   Chansaenroj, Jira ^b   Junyangdikul, Pairoj ^c   Swangvaree, Sukumarn ^d   Karalak, Anant ^d   Niruthisard, Somchai ^b   Poovorawan, Yong ^b  

^a SRINAKHARINWIROT UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c Samitivej Srinakharin Hospital   (Thailand)

^d NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

Direct sequencing; Genotyping; HPV; INNO LiPA

Indexed keywords

EID: 84856256987     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Astori G, Arzese A, Pipan C, et al (1997). Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism. Virus Res, 50, 57-63.
2. Bharadwaj M, Hussain S, Nasarc V, et al (2009). HPV & HPV vaccination:Issues in developing countries. Indian J Med Res, 130, 327-333.
3. Bosch FX, Burchell AN, Schiffman M, et al (2008). Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine, 26, 1-16.
4. Brink AA, Snijders PJ, Meijer CJ (2007). HPV detection methods. Dis Markers, 23, 273-281.
5. Carvalho NO, Castillo DM, Perone C, et al (2010). Comparison of HPV genotyping by type-specific pc r and sequencing. Mem Inst Oswaldo Cruz, Rio de Janeiro, 105, 73-78.
6. Chansaenroj J, Lurchachaiwong W, Termrungruanglert W, et al (2010). Prevalence and genotypes of human papillomavirus among Thai women. Asian Pacific J Cancer Prev, 11, 117-122.
7. Choi Y-D, Jung W-W, Nam J-H, et al (2005). Detection of HPV genotypes in cervical lesions by the HPV DNA chip and sequencing. Ginecol Oncol, 98, 369-375.
8. Coutlée F, Rouleau D, Petignat P, et al (2006). Enhanced detection and typing of humanpapillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol, 44, 1998-2006.
9. De Villiers EM, Fauquet C, Broker TR, et al (2004). Classification of papillomaviruses. Virology, 324, 17-27.
10. Doorbar J (2006). Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci, 110, 525-541.
11. Ermela A, Qadadria B, Morishitab A, et al (2010). Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay. J Virol Methods, 169, 154-161.
12. Feng Q, Cherne S, Winer RL, et al (2009). Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J Clin Microbiol, 47, 547-53.
13. Fontaine V, Mascaux C, Weyn C, et al (2007). Evaluation of combined general primermediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens. J Clin Microbiol, 45, 928-934.
14. Gravitti PE, Peyton CL, Alessi TQ, et al (2000). Improved amplification of genital humam papillomaviruses. J Clin Microbiol, 38, 357-361.
15. Grm HS, Bergant M, Banks L (2009). Human papillomavirus infection, cancer & therapy. Indian J Med Res, 130, 277-285.
16. Hlaing T, Yip YC, Ngai KL, et al (2010). Distribution of human papillomavirus genotypes among cervical intraepithelial neoplasia and invasive cancers in Macao. J Med Virol, 82, 1600-5.
17. Ho GY, Studentsov YY, Bierman R, et al (2004). Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol. Biomarkers Prev, 13, 110-116.
18. Kleter B, van Doorn L-J, Schrauwen L, et al (1999). Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol, 37, 2508-2517.
19. Lee SH, Vigliotti VS, Vigliotti JS, et al (2007). Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. Infect Agents Cancer, 2, 1-11.
20. Lin K, Roosinovich E, Ma B, et al (2010). Therapeutic HPV DNA vaccines. Immunol Res, 47, 86-112.
21. Lurchachaiwong W, Junyangdikul P, Payungporn S, et al (2009). Relationship between hybrid capture II ratios and DNA amplification of E1, E6 and L1 genes used for the detection of human papillomavirus in samples with different cytological findings. Asian Pac J Allergy Immunol, 27, 217-24.
22. Meijer CJ, Snijders PJ, Castle PE (2003). Clinical utility of HPV genotyping. Gynecol Oncol, 103, 12-17.
23. Mendez F, Munoz N, Posso H, et al (2005). Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis, 192, 1158-1165.
24. Montaldo C, Mastinu A, Quartuccio M, et al (2007). Detection and genotyping of human papillomavirus DNA in samples from healthy Sardinian patients: a preliminary study. J Oral Pathol Med, 36, 482-487.
25. Nielsen A, Kjaer SK, Munk C, et al (2008). Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12,000 younger and older Danish women. Sex Transm Dis, 35, 276-82.
26. Parkin DM, Bray F, Ferlay J, et al (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
27. Sabol I, Salakova M, Smahelova J, et al (2008). Evaluation of Different Techniques for Identification of Human papillomavirus types of low prevalence. J Clin Micro, 46, 1606-1613.
28. Smith JS, Lindsay L, Hoots B, et al (2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer, 121, 621-32.
29. Sukasem C, Pairoj W, Saekang N, et al (2011). Molecular epidemiology of human papillomavirus genotype in women with high-grade squamous intraepithelial lesion and cervical cancer: will a quadrivalent vaccine be necessary in Thailand? J Med Virol, 83, 119-26.
30. Tsao KC, Huang CG, Kuo YB, et al (2010). Prevalence of human papillomavirus genotypes in northern Taiwanese women. J Med Virol, 82, 1739-45.
31. Van Hamont D, Van Ham MA, Bakkers JM, et al (2006). Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the Roche linear array HPV genotyping test. J Clin Microbiol, 449, 3122-9.
32. Verteramo R, Pierangeli A, Calzolari E, et al (2006). Direct sequencing of HPV DNA detected in gynaecologic outpatients in Rome, Italy. Microbes Infect, 8, 2517-2521.
33. Walboomers JM, Jacobs MV, Manos MM, et al (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 189, 12-9.
34. Wheeler CM, Hunt WC, Joste NE, et al (2009). Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J. Natl Cancer Inst, 101, 475-487.